“By embracing a DTC sales model, pharmaceutical companies and the patients that consume their drugs can essentially cut PBMs and other middlemen out of the picture,” writes Pipes.
getty
Several Big Pharma companies have started selling their drugs directly to consumers (DTC). This shift — driven in part by President Trump’s push for lower drug prices and fewer middlemen — has garnered relatively little media coverage. But the implications for American patients, employers, and the healthcare…
Continue Reading
News Source: www.forbes.com
Leave a Reply